bendamustine hydrochloride has been researched along with Brain Neoplasms in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Colapietro, A; Cristiano, L; Delle Monache, S; Festuccia, C; Gravina, GL; Mancini, A; Marampon, F; Mehrling, T; Pompili, S; Tombolini, V; Vetuschi, A; Vitale, F | 1 |
| Hong, SH; Kang, JH; Kim, YS; Kwak, YK; Lee, SW; Sung, S | 1 |
| Chinnaiyan, P; Neuger, A; Pan, E; Smith, P; Yu, D; Yu, HH; Zhao, X | 1 |
| Chamberlain, MC; Colman, H; Kim, BT; Raizer, J | 1 |
| Chamberlain, MC; Johnston, SK | 1 |
| Höffken, K; Kath, R; Merkle, K; Semrau, R; Zulkowski, K | 1 |
3 trial(s) available for bendamustine hydrochloride and Brain Neoplasms
| Article | Year |
|---|---|
Phase I study of bendamustine with concurrent whole brain radiation therapy in patients with brain metastases from solid tumors.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Bendamustine Hydrochloride; Brain Neoplasms; Breast Neoplasms; Carcinoma, Neuroendocrine; Carcinoma, Non-Small-Cell Lung; Cohort Studies; Combined Modality Therapy; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Maximum Tolerated Dose; Melanoma; Middle Aged; Nitrogen Mustard Compounds; Survival Analysis; Treatment Outcome | 2014 |
Salvage therapy with bendamustine for temozolomide refractory recurrent anaplastic gliomas: a prospective phase II trial.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Bendamustine Hydrochloride; Brain Neoplasms; Dacarbazine; Drug Resistance, Neoplasm; Female; Glioma; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Salvage Therapy; Temozolomide; Treatment Outcome | 2017 |
Salvage therapy with single agent bendamustine for recurrent glioblastoma.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Bendamustine Hydrochloride; Brain Neoplasms; Disease-Free Survival; Female; Glioblastoma; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Recurrence, Local; Nitrogen Mustard Compounds; Salvage Therapy | 2011 |
3 other study(ies) available for bendamustine hydrochloride and Brain Neoplasms
| Article | Year |
|---|---|
The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects and is synergistic with radiotherapy in preclinical models of glioblastoma.
Topics: Animals; Antineoplastic Agents, Alkylating; Bendamustine Hydrochloride; Benzimidazoles; Brain Neoplasms; Cell Line, Tumor; Female; Glioblastoma; Histone Deacetylase Inhibitors; Humans; Mice; Vorinostat | 2018 |
Intracranial control and survival outcome of tyrosine kinase inhibitor (TKI) alone versus TKI plus radiotherapy for brain metastasis of epidermal growth factor receptor-mutant non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Bendamustine Hydrochloride; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Disease Progression; ErbB Receptors; Female; Humans; Incidence; Male; Middle Aged; Mutation; Protein Kinase Inhibitors; Protein-Tyrosine Kinases | 2018 |
Regression of brain metastases from breast carcinoma after chemotherapy with bendamustine.
Topics: Adult; Antineoplastic Agents; Bendamustine Hydrochloride; Brain Neoplasms; Breast Neoplasms; Female; Humans; Liver Neoplasms; Nitrogen Mustard Compounds; Treatment Outcome | 2002 |